We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Auto-summary of recent filing activity and financial trends · not investment advice
Eli Lilly's recent disclosure activity was most frequent with 20 Form 4 filings (Insider Transaction Statements), indicating active insider trading. Additionally, 3 Form 8-K filings (Current Reports), and one each of Form 10-Q (Quarterly Report) and DEF 14A (Definitive Proxy Statement) were submitted. As the provided data lacks information on revenue and net income trends, it is difficult to ascertain financial performance trends from this material alone.
Latest filings collected from EDGAR